Silverarc Capital Management, LLC Delcath Systems, Inc. Transaction History

Silverarc Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$8.44 - $12.65 $837,155 - $1.25 Million	-99,189 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$9.54 - $15.1 $564,663 - $893,753	59,189 Added 147.97%	99,189 $1.25 Million
Q1 2021 May 18, 2021	SELL	$12.42 - $23.81 $3.87 Million - $7.42 Million	-311,616 Reduced 88.62%	40,000 $497,000
Q4 2020 Feb 16, 2021	BUY	$10.55 - $18.69 $3.71 Million - $6.57 Million	351,616 New	351,616 $6.3 Million

7.93M

118K

69.9K

Ticker DCTH
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 8,597,680
Market Cap $89.1M
Description
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling syste...

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Silverarc Capital Management, LLC with notifications on news.